CoChat

Vascular inflammation: a role in vascular disease in hypertension?

Virdis, Agostino, Schiffrin, Ernesto L. · 2003 · Current Opinion in Nephrology and Hypertension

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

PURPOSE OF REVIEW: In this review, we summarize the more recent clinical evidence highlighting the importance of vascular inflammation in terms of clinical risk prediction, and the mechanisms mediating the upregulation of inflammatory mediators in cardiovascular disease and hypertension. RECENT FINDINGS: Markers of inflammation have been shown to be upregulated in different forms of cardiovascular disease, and to correlate with vascular risk. Atherosclerosis is characterized by chronic inflammation of the vascular wall. The I-kappaB/nuclear factor-kappaB system is considered a major intracellular inflammatory pathway, mediating most of the vascular inflammatory responses. Increasing evidence indicates that hypertension, through the vasoactive peptides angiotensin and endothelin-1, promotes and accelerates the atherosclerotic process via inflammatory mechanisms. In animal and human studies proinflammatory properties of angiotensin II have been demonstrated in large conduit and small arteries, in the kidney as well as in the heart. The angiotensin II receptors involved in the inflammatory process and the interaction between angiotensin II and nitric oxide in mediating vascular inflammation have been identified. In addition, recent advances concerning the role of endothelin-1 as another important mediator of chronic inflammation in the vascular wall has been documented, and the relationship between endothelin-1 and angiotensin II on vascular inflammation demonstrated. SUMMARY: Inflammatory mechanisms are important participants in the pathophysiology of hypertension and cardiovascular disease. The identification of useful markers of inflammation, of new therapeutic targets to interfere with these mechanisms, and the evaluation of the efficacy of antiinflammatory treatments will allow progress in our ability to combat cardiovascular disease and the complications of hypertension.

Overview

Integrity signals

Registry

Crossref · 10.1097/00041552-200303000-00009

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 53 references

Research works printed but not linked: 2

  1. Huang, 1997, Circulation, 46, 4219
  2. Touyz, 2000, Pharmacol Rev, 52, 639

Cited by

See all 182

Metadata

Authors
Virdis, A., & Schiffrin, E. L.
Affiliations
Montreal Clinical Research Institute (CA)
Corresponding author
Schiffrin, Ernesto L.
Venue
Current Opinion in Nephrology and Hypertension
Published
2003-03
Volume
12
Issue
2
Pages
181-187
ISSN
1062-4821 (ISSN-L)
OpenAlex
W2332421164
Cited by
182
References
53
Citations by year
2026: 2 · 2025: 4 · 2024: 3 · 2023: 3 · 2022: 6 · 2021: 13 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 9 · 2016: 11 · 2015: 7 · 2014: 9 · 2013: 7 · 2012: 11
FWCI
6.51
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Nephrology & Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Renin-Angiotensin System Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
Keywords
vascular inflammation, hypertension, cardiovascular disease, atherosclerosis, NF-κB signaling, angiotensin II, endothelin-1, nitric oxide, inflammatory markers, angiotensin II receptor, anti-inflammatory therapy
MeSH terms
Angiotensin II, Arteriosclerosis, Endothelium, Vascular, Female, Humans, Hypertension, Male, Nitric Oxide, Predictive Value of Tests, Prognosis, Sensitivity and Specificity, Severity of Illness Index, Vascular Diseases, Endothelins, Risk Assessment, Inflammation Mediators, Vascular Endothelial Growth Factor A

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vascular inflammation: a role in vascular disease in hypertension? https://app.cochat.ai/papers/10.1097/00041552-200303000-00009
The paper
Virdis, A., & Schiffrin, E. L. (2003). Vascular inflammation: a role in vascular disease in hypertension? Current Opinion in Nephrology and Hypertension. https://doi.org/10.1097/00041552-200303000-00009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.